Newsroom

IRVING, Texas--(BUSINESS WIRE)--Nexstar Media Group, Inc. (NASDAQ: NXST) announced today that its Board of Directors declared a quarterly cash dividend of $1.86 per share of its common stock. The dividend is payable on Friday, August 28, 2026, to shareholders of record on Friday, August 14, 2026. While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its discretio...

パリ--(BUSINESS WIRE)--（ビジネスワイヤ） -- モータースポーツの世界統括団体であり、世界のモビリティ関連団体を束ねる国際自動車連盟（FIA）は、FIA世界ラリー選手権（WRC）およびFIA欧州ラリー選手権（ERC）の商業権に関する画期的な長期契約を締結したと発表しました。今回の契約は、コスモビリスおよびパーク・スクエア・キャピタルによるWRCプロモーターGmbHの買収を受けて実現したものです。 両選手権の歴史上最大規模となる今回の契約は、WRCおよびERCにとって新たな章の幕開けとなります。モハメド・ビン・スライエムFIA会長のビジョンを支える取り組みとして、競技への大規模な新規投資を実現し、今後長年にわたりFIAの世界トップレベルのモータースポーツ事業の強化と成長を後押しします。 今回の契約はラリーコミュニティ全体のために設計されており、ファン、競技者、大会主催者、そしてFIA加盟クラブに具体的な利益をもたらすことを目的としています。この契約を通じて、ラリー競技はより身近で、より競争力が高く、商業的にも成功するスポーツへと発展していきます。競技の成長が進む中で...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Wise Group plc (NASDAQ: WSE) between May 11, 2026 and July 23, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Wise Group plc investors under the federal securities laws.To join the Wise Group plc class action, go to https://rosenlegal.com/cases/wise-group-plc/join or call Phillip Kim, Es...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). Thi...

MANILA, Philippines--(BUSINESS WIRE)--The UNITE Parliamentarians Network for Global Health and the AHF Global Public Health Institute will convene two urgent panel sessions on regional health security and global health financing at the UNITE Global Summit 2026 in Manila, Philippines, on Aug. 3, rallying parliamentarians to translate political will into legislation, financing, and oversight. With an evolving global health architecture, parliamentarians are playing an increasingly important role...

SAN DIEGO--(BUSINESS WIRE)--The case alleges Wix and certain of its executives made false and/or misleading statements to investors....

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”). Park Ha develops and sells skincare and cosmetics products.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Bloom Energy Corporation (“Bloom Energy” or the “Company”) (NYSE: BE) common stock between February 27, 2025 and July 8, 2026, inclusive (“the Class Period”).If you suffered a loss on your Bloom Energy investments, you have until September 28, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced that, on July 30, 2026, CareDx granted to James McNally, the Company’s newly appointed Executive Advisor, certain stock awards as an inducement material to Mr. McNally’s employment with CareDx. CareDx granted 15,822 shares of common stock restricted stock units (RSUs) to Mr. McNally. The RSU awards were made pursua...